Modulating effect of Hypericum perforatum extract on astrocytes in MPTP induced Parkinson's disease in mice

M Mohanasundari1, M Sabesan

  • 1Department of Zoology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India.

Insights

Hypericum perforatum extract shows neuroprotective effects against Parkinson's disease in mice. It inhibits monoamine oxidase-B activity and reduces astrocyte activation caused by MPTP.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor deficits.
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin used to model PD in animal studies.
  • Astrocyte activation is implicated in the neuroinflammatory processes of PD.

Purpose of the Study:

  • To evaluate the neuroprotective potential of Hypericum perforatum extract (HPE).
  • To investigate the effect of HPE on astrocyte reactions in an MPTP-induced mouse model of Parkinson's disease.
  • To assess the impact of HPE on monoamine oxidase-B (MAO-B) activity.

Main Methods:

  • Mice were treated with MPTP (20 mg/kg at 2-hour intervals) to induce Parkinsonism.
  • Mice received treatment with Hypericum perforatum extract (HPE).
  • MAO-B activity and astrocyte activation in the striatal area were measured.

Main Results:

  • HPE treatment inhibited monoamine oxidase-B (MAO-B) activity.
  • HPE significantly reduced MPTP-induced astrocyte activation in the striatal region.
  • These findings suggest a neuromodulating effect of HPE.

Conclusions:

  • Hypericum perforatum extract demonstrates neuroprotective properties in an MPTP-induced Parkinson's disease mouse model.
  • HPE may offer therapeutic benefits by modulating MAO-B activity and neuroinflammation.
  • Further research into HPE as a potential treatment for Parkinson's disease is warranted.

Related Concept Videos